In vivo persistence of genetically modified T cells generated ex vivo using the fibronectin CH296 stimulation method.
- Published in:
- Cancer Gene Therapy, 2008, v. 15, n. 8, p. 508, doi. 10.1038/cgt.2008.21
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2008 AND VI 15 AND IP 8
Results: 7
1
2
Antiangiogenic systemic gene therapy combined with doxorubicin administration induced caspase 8 and 9-mediated apoptosis in endothelial cells and an anti-metastasis effect.
- Published in:
- Cancer Gene Therapy, 2008, v. 15, n. 8, p. 535, doi. 10.1038/cgt.2008.20
- By:
- Publication type:
- Article
3
Effects of DNAzymes targeting Aurora kinase A on the growth of human prostate cancer.
- Published in:
- Cancer Gene Therapy, 2008, v. 15, n. 8, p. 517, doi. 10.1038/cgt.2008.22
- By:
- Publication type:
- Article
4
Radiation improves gene delivery by a novel transferrin-lipoplex nanoparticle selectively in cancer cells.
- Published in:
- Cancer Gene Therapy, 2008, v. 15, n. 8, p. 496, doi. 10.1038/cgt.2008.26
- By:
- Publication type:
- Article
5
Systemic delivery of HK Raf-1 siRNA polyplexes inhibits MDA-MB-435 xenografts.
- Published in:
- Cancer Gene Therapy, 2008, v. 15, n. 8, p. 485, doi. 10.1038/cgt.2008.29
- By:
- Publication type:
- Article
6
Conditionally replicating E1B-deleted adenovirus driven by the squamous cell carcinoma antigen 2 promoter for uterine cervical cancer therapy.
- Published in:
- Cancer Gene Therapy, 2008, v. 15, n. 8, p. 526, doi. 10.1038/cgt.2008.37
- By:
- Publication type:
- Article
7
Expression-targeted gene therapy for the treatment of transitional cell carcinoma.
- Published in:
- Cancer Gene Therapy, 2008, v. 15, n. 8, p. 543, doi. 10.1038/cgt.2008.7
- By:
- Publication type:
- Article